# VAST - Ventricular Arrhythmia Suppression Trial

> **NCT00158912** · PHASE4 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 550 (—)

## Conditions studied

- Tachycardia

## Interventions

- **DEVICE:** Implantable Cardioverter Defibrillator

## Key facts

- **NCT ID:** NCT00158912
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 550 (—)
- **Last updated:** 2006-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158912, "VAST - Ventricular Arrhythmia Suppression Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00158912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*